Skip to main content
LAB logo

LAB · Standard Biotools Inc. · Debt

Track LAB — free
$0.61 -0.03 (-4.72%) At close · Oct 23
Market Cap
$237.75M
Shares
392.58M
Volume · Oct 23 853K Avg daily vol (3M) 1.36M

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-06-30 USD 5,621,000 10-Q filed 2026-08-05
Noncurrent convertible debt 2026-06-30 USD 299,000 10-Q filed 2026-08-05
Noncurrent operating lease liabilities 2026-06-30 USD 22,167,000 10-Q filed 2026-08-05
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1162194 CUSIP 34385P108 13F (30d) 5 filings 5 filers Visit website Investor relations